20 Aug 2024
// PRESS RELEASE
01 Jul 2024
// PRESS RELEASE
03 Jun 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #7B82
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Attending
26-28 November, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
Severity: Warning
Message: Undefined variable $tile1
Filename: tabs/exhibitions.php
Line Number: 43
Backtrace:
File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler
File: /var/www/html/application/models/CmnPec.php
Line: 1626
Function: view
File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create
File: /var/www/html/application/views/include/party/indexNew.php
Line: 86
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 1368
Function: include
File: /var/www/html/application/controllers/PharmaServices.php
Line: 4582
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Booth #7B82
08-10 October, 2024
CPhI India 2024CPhI India 2024
Industry Trade Show
Attending
26-28 November, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-novo-s-parent-buys-catalent-for-us-16-5-bn-fujifilm-merck-kgaa-axplora-lonza-expand-capabilities
20 Aug 2024
// PRESS RELEASE
https://www.aurigeneservices.com/sites/default/files/2024-08/Media%20note-%20DRL-APSL%20partnership%20with%20Kainomyx.pdf
01 Jul 2024
// PRESS RELEASE
https://www.aurigeneservices.com/sites/default/files/2024-07/APSL%20Edity%20Media%20note.pdf
03 Jun 2024
// PRESS RELEASE
https://www.aurigeneservices.com/sites/default/files/2024-06/Genomevalley-facility-press%20release-final-3rd-June-2024.pdf
19 Apr 2024
// PRESS RELEASE
https://www.aurigeneservices.com/sites/default/files/2024-04/APSL%20Vipergen%20Partnership_Media%20Note.pdf
04 Apr 2024
// PRESS RELEASE
https://www.aurigeneservices.com/sites/default/files/2024-04/Aurigene-Pharma-Aurigene.AI_.pdf
03 Apr 2024
// BUSINESSWIRE
Details:
Fermenta Biotech will exclusively license its biocatalytic technology for synthesis of Molnupiravir (Molflu) and supply its enzyme Candida Antarctica B Lipase (CAL B) to Aurigene. Molnupiravir API manufactured by Aurigene will be utilised by Dr Reddy’s for its formulation.
Lead Product(s): Molnupiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Molflu
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Fermenta Biotech Limited
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 21, 2022
Lead Product(s) : Molnupiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Fermenta Biotech Limited
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Fermenta Biotech will exclusively license its biocatalytic technology for synthesis of Molnupiravir (Molflu) and supply its enzyme Candida Antarctica B Lipase (CAL B) to Aurigene. Molnupiravir API manufactured by Aurigene will be utilised by Dr Reddy’s...
Brand Name : Molflu
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 21, 2022
Details:
This next-generation adenine nucleotide translocase (ANT) inhibitor, PENAO, was shown to be safe and well-tolerated in a phase I clinical trial conducted in Australia where encouraging efficacy data was observed.
Lead Product(s): PENAO,Sirolimus
Therapeutic Area: Oncology Brand Name: PENAO
Study Phase: Phase I/ Phase IIProduct Type: Small molecule
Sponsor: PENAO Pty Ltd
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement August 18, 2021
Lead Product(s) : PENAO,Sirolimus
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : PENAO Pty Ltd
Deal Size : Undisclosed
Deal Type : Agreement
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
Details : This next-generation adenine nucleotide translocase (ANT) inhibitor, PENAO, was shown to be safe and well-tolerated in a phase I clinical trial conducted in Australia where encouraging efficacy data was observed.
Brand Name : PENAO
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 18, 2021
Details:
Through this MOU, the parties will seek to collaborate on efforts to determine market potential for zoliflodacin, therapeutic value to patients and explore possibilities to enter into future manufacturing and supply agreements.
Lead Product(s): Zoliflodacin,Ceftriaxone,Azithromycin
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: The Global Antibiotic Research and Development Partnership
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement December 17, 2020
Lead Product(s) : Zoliflodacin,Ceftriaxone,Azithromycin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : The Global Antibiotic Research and Development Partnership
Deal Size : Undisclosed
Deal Type : Agreement
GARDP, Dr. Reddy’s and Aurigene Pharmaceutical Services Limited Sign MOU for Antibiotic Access T...
Details : Through this MOU, the parties will seek to collaborate on efforts to determine market potential for zoliflodacin, therapeutic value to patients and explore possibilities to enter into future manufacturing and supply agreements.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 17, 2020
Services
API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Pharma Service : API Manufacturing
Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
API & Drug Product Development
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?